Get the Stockscreener App
3.82
9.46%
0.33
After Hours:
3.83
0.01
+0.26%
Codexis Inc stock is traded at $3.82, with a volume of 788.66K.
It is up +9.46% in the last 24 hours and up +20.89% over the past month.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
See More
Previous Close:
$3.49
Open:
$3.46
24h Volume:
788.66K
Relative Volume:
1.36
Market Cap:
$310.86M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-4.4941
EPS:
-0.85
Net Cash Flow:
$-57.06M
1W Performance:
+19.75%
1M Performance:
+20.89%
6M Performance:
-2.55%
1Y Performance:
+97.93%
1-Day Range:
$3.46
$3.84
1-Week Range:
$3.075
$3.84
52-Week Range:
$1.51
$4.91
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
abrdn plc Raises Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock By Investing.com - Investing.com Canada
Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock - Investing.com India
Codexis to Participate in Upcoming Healthcare Conferences - The Manila Times
Codexis (NASDAQ:CDXS) Earns Hold Rating from Benchmark - MarketBeat
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 - Yahoo Finance
Codexis, Inc. Announces Strong Third Quarter 2024 Financial Results - Defense World
Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Codexis, Inc. (NASDAQ:CDXS) Q3 2024 Earnings Call Transcript - Insider Monkey
Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Earnings call: Codexis reports revenue growth and strategic focus in Q3 2024 - Investing.com Canada
Codexis Inc Q3 2024 Earnings: Revenue Hits $12.83M, Beating Esti - GuruFocus.com
Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ... - Yahoo Finance
Codexis Reports Strong Q3 Revenue Growth - TipRanks
Codexis: Q3 Earnings Snapshot - Houston Chronicle
Codexis Reports Third Quarter 2024 Financial Results - GlobeNewswire
Assenagon Asset Management S.A. Increases Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis, Inc. (NASDAQ:CDXS) Short Interest Update - MarketBeat
Opaleye management buys $72,720 in Codexis stock By Investing.com - Investing.com Canada
Opaleye management buys $72,720 in Codexis stock - Investing.com
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting - GlobeNewswire
Codexis (CDXS) Set to Announce Earnings on Thursday - MarketBeat
Codexis (CDXS) to Post Quarterly Earnings on Thursday - Defense World
Codexis, Inc. (NASDAQ:CDXS) Announces Departure of Chief Financial Officer and Entry into Separation Agreement - Defense World
Codexis announces CFO transition and consulting agreement By Investing.com - Investing.com Australia
Codexis announces CFO transition and consulting agreement - Investing.com
Codexis (NASDAQ:CDXS) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Codexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Codexis Inc. (CDXS) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Codexis announces employment inducement grants - Yahoo Finance
Codexis Announces New Employment Inducement Grants - The Manila Times
Codexis to Report Third Quarter 2024 Financial Results on October 31 - The Manila Times
Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
American Century Companies Inc. Acquires 16,019 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis appoints new CTO and CFO By Investing.com - Investing.com Australia
Biocatalysts Market Attractive Growth Proposition Seen in 2024: BASF SE, DSM, Codexis - openPR
Codexis secures $31 million to extend cash runway - Investing.com
Codexis appoints new CTO and CFO - Investing.com India
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):